Rapid testosterone cycling and chemotherapy for prostate cancer: a way forward or return to the past?
Matthew R
MR
Smith
D000818:Animals; D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D000077143:Docetaxel; D007987:Gonadotropin-Releasing Hormone / Q000819:agonists; D006801:Humans; D016729:Leuprolide / Q000008:administration & dosage; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000378:metabolism*; D051381:Rats; D043823:Taxoids / Q000008:administration & dosage / Q000627:therapeutic use; D013739:Testosterone / Q000008:administration & dosage / Q000378:metabolism*
D018931:Antineoplastic Agents, Hormonal; D043823:Taxoids; D000077143:Docetaxel; D007987:Gonadotropin-Releasing Hormone; D013739:Testosterone; D016729:Leuprolide